Guardant Health Inc. (GH) exhibits 64.5% gross margins and -17.4% return on invested capital within Health Care (Medical Specialities), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.
Sustained 64.5% gross profitability converts into -44.5% operating margin and -17.4% ROIC, outpacing sector cost of capital.
ROIC: -17.4% // GM: 64.5%YoY revenue trajectory of +32.9% paired with -0.94% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +32.9% // FCF YLD: -0.94%Altman Z-Score of 5.44 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 5.44 // F-SCORE: 6/9Trading at 24.0x trailing P/E (19.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $178.80 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend -42.4% net margins.
NET MARGIN: -42.4% // D/E: 0.85x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for GH & activate live FRED threshold breach alerts.